Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Rankning i aktier #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Aktiekurs
$3.86
Marknadsvärde
$21.49M
Förändring (1 dag)
-0.17%
Förändring (1 år)
-25.27%
Land
JP
Handel Human Metabolome Technologies, Inc. (6090)

Kategori

Aktiekurshistorik för Human Metabolome Technologies, Inc. (6090)
Högsta slutkurs: $3.90 den 2026-08-01

Lägsta slutkurs: $38.92 den 2013-12-01
Aktiekurshistorik för Human Metabolome Technologies, Inc. från 2013 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 6.42%
2025 5.53%
2024 -8.60%
2023 -16.34%
2022 -3.84%
2021 -27.40%
2020 -0.20%
2019 -31.00%
2018 -39.33%
2017 33.64%
2016 94.29%
2015 -35.63%
2014 -72.82%
2013 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$544.55 39.36%
US
$1.03K 56.18%
NL
$153.89 451.38%
US
$117.42 -19.34%
AU
$754.06 8.70%
CH